Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 343, Issue 2, Pages 591-596Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2006.03.015
Keywords
chronic intermittent hypoxia; NF-kappa B; obstructive sleep apnea; cardiovascular diseases; inflammation
Categories
Ask authors/readers for more resources
Obstructive sleep apnea (OSA) is an important risk factor for cardiovascular morbidity and mortality. The mechanisms through which OSA promotes the development of cardiovascular disease are poorly understood. In this study, we tested the hypotheses that chronic exposure to intermittent hypoxia and reoxygenation (CIH) is a major pathologic factor causing cardiovascular inflammation, and that CIH-induces cardiovascular inflammation and pathology by activating the NF-kappa B pathway. We demonstrated that exposure of mice to CIH activated NF-kappa B in cardiovascular tissues, and that OSA patients had markedly elevated monocyte NF-kappa B activity, which was significantly decreased when obstructive apneas and their resultant CIH were eliminated by nocturnal CPAP therapy. The elevated NF-kappa B activity induced by CIH is accompanied by and temporally correlated to the increased expression of NOS protein, a putative and important NF-kappa B-dependent gene product. Thus, CIH-mediated NF-kappa B activation may be a molecular mechanism linking OSA and cardiovascular pathologies seen in OSA patients. (c) 2006 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available